Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in Progressive Multiple Sclerosis
NCT01950234Phase 2Terminated
- Sponsor
- University of Minnesota
- Start
- Apr 2014
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing ACTH Arm with Placebo Arm (2 arms). Primary endpoint: Proportion of Patients Exhibiting a 20% Worsening in Timed 25-Foot Walk at 36 months. Started Apr 2014; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01950234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950234.